Friday, 16 October 2026European Markets

ODFJELL SER. A And CTT CORREIOS PORT Have A High Dividend Yield And Return On Equity In The Industrials Sector.

Loading stream...

(VIANEWS) - ODFJELL SER. A (ODF.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Industrials sector.

Financial Asset Price Forward Dividend Yield Return on Equity
ODFJELL SER. A (ODF.OL) kr142.20 11.77% 31.7%
CTT CORREIOS PORT (CTT.LS) €4.41 3.84% 21.62%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ODFJELL SER. A (ODF.OL)

11.77% Forward Dividend Yield and 31.7% Return On Equity

Odfjell SE provides services for the transportation and storage of bulk liquid chemicals, acids, edible oils, and other specialty products in North America, South America, Norway, the Netherlands, rest of Europe, the Middle East, Asia, Africa, and Australasia. The company operates through Chemical Tankers and Tank Terminals segments. It owns and operates chemical tankers that offer global and regional transportation; and tank terminals, which provide storage of various chemical and petroleum products. As of December 31, 2023, it operated a chemical tanker fleet of 68 vessels, including 46 owned/leased, 5 operational bareboat, 14 time chartered, and 3 pool vessels. The company's terminal network consists of 459 tanks with 1.3 million cubic meters of storage capacity. Odfjell SE was incorporated in 1914 and is headquartered in Bergen, Norway.

Earnings Per Share

As for profitability, ODFJELL SER. A has a trailing twelve months EPS of kr34.1.

PE Ratio

ODFJELL SER. A has a trailing twelve months price to earnings ratio of 4.17. Meaning, the purchaser of the share is investing kr4.17 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.7%.

More news about ODFJELL SER. A.

2. CTT CORREIOS PORT (CTT.LS)

3.84% Forward Dividend Yield and 21.62% Return On Equity

CTT - Correios De Portugal, S.A., together with its subsidiaries, provides postal and financial services worldwide. It operates through Mail, Express & Parcels, Financial Services & Retail, and Bank segments. The company offers courier and urgent mail transport services; postal financial services; contact center services; and banking services. It also engages in the business of payments related to collection of invoices and fines. In addition, the company enables the payment of various services and utilities through a network of approximately 5,000 agents covering business outlets as stationery stores, tobacco shops, kiosks, and supermarkets. It operates a retail network of 569 post offices; 1,806 postal agencies; 219 postal delivery offices; 4,089 postal delivery routes; and a fleet of 4,415 vehicles. The company was formerly known as Correio Publico. CTT - Correios De Portugal, S.A. was founded in 1520 and is headquartered in Lisbon, Portugal.

Earnings Per Share

As for profitability, CTT CORREIOS PORT has a trailing twelve months EPS of €0.39.

PE Ratio

CTT CORREIOS PORT has a trailing twelve months price to earnings ratio of 11.31. Meaning, the purchaser of the share is investing €11.31 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.62%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.3%, now sitting on 1.08B for the twelve trailing months.

Sales Growth

CTT CORREIOS PORT's sales growth for the next quarter is 5.6%.

More news about CTT CORREIOS PORT.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com